A drug known to reduce mortality rate in heart failure patients has now been found very effective when administered early in patients following an acute (ST elevated) myocardial infarction. This effect,say the investigators, was consistent across all study sub-groups, but was "particularly obvious in patients undergoing reperfusion within six hours of symptom onset". Eplerenone, a mineralocorticoid receptor antagonist (MRA), has already been investigated ...
Read More
You have just read an article categorized health
titled Eplerenone Reduces Primary Endpoint in Patients With Acute Myocardial Infarction.
Written by:
editor -
Thursday, May 1, 2014
There are currently no comments for "Eplerenone Reduces Primary Endpoint in Patients With Acute Myocardial Infarction"
Post a Comment